Health & Wellness
Migraine & Headaches Quiz
Aura, triggers, and treatment — what's actually going on inside your head
Aura, triggers, and treatment — what's actually going on inside your head
Migraine ranks as the second leading cause of disability worldwide, affecting over 1 billion people. Beyond simple 'bad headaches', migraines involve cortical spreading depression, trigeminal nerve activation, and CGRP release — and modern medicine now has a generation of CGRP-targeted drugs designed specifically for them.
Each round presents 10 randomized questions from a pool of 50, with four multiple-choice options and instant feedback after every answer. Your final score comes with a performance tier and shareable results.
You'll cover migraine vs tension vs cluster headaches, ICHD-3 diagnostic criteria, the four phases of a migraine attack, aura and cortical spreading depression, common triggers, the triptan class (sumatriptan since 1991), the new CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab), Botox for chronic migraine, and red flags that warrant urgent evaluation.
Migraines tend to be unilateral, pulsating, moderate-to-severe, worsened by activity, and often come with nausea and light/sound sensitivity. Tension-type headaches are usually bilateral, pressing or tightening, and not aggravated by routine activity.
Aura is a set of reversible neurological symptoms — most often visual disturbances like flickering zigzags or blind spots — lasting 5 to 60 minutes, typically before the headache begins.
Triptans are 5-HT1B/1D serotonin receptor agonists that constrict cranial blood vessels and inhibit release of inflammatory neuropeptides like CGRP. Sumatriptan, the first triptan, was approved in 1991.
Last updated: April 2026